Gsk (GSK) Current Leases (2016 - 2018)

Gsk (GSK) has 3 years of Current Leases data on file, last reported at $30.9 million in Q4 2018.

• In Q4 2018, Current Leases rose 1.13% year-over-year to $30.9 million; the TTM figure through Dec 2018 stood at $30.9 million (up 1.13% YoY), while the FY2018 annual figure was $32.1 million, up 8.18% from the prior year.
• Current Leases grew to $30.9 million in Q4 2018, from $30.5 million in the prior quarter.
• Across five years, Current Leases topped out at $30.9 million in Q4 2018 and bottomed at $28.6 million in Q4 2016.
• A 3-year average of $30.0 million and a median of $30.5 million in 2017 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2017 — Current Leases rose 6.79% — and 2018, when it increased 1.13%.
• Year by year, Current Leases stood at $28.6 million in 2016, then advanced by 6.79% to $30.5 million in 2017, then gained by 1.13% to $30.9 million in 2018.
• The last three Current Leases figures came in at $30.9 million (Q4 2018), $30.5 million (Q4 2017), and $28.6 million (Q4 2016), per Business Quant data.

Peer Comparison